Medicare AdvantageReimbursementMedium impact
MA09.009y, Reimbursement for Radiopharmaceutical Agents
Independence Blue Cross·Nuclear Medicine, Radiology, Diagnostic Imaging +1 more·Claims & Billing
Effective date
Apr 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage has updated their reimbursement policy for radiopharmaceutical agents, effective April 1, 2025. This medical coding policy change will affect billing and reimbursement for nuclear medicine procedures and diagnostic imaging services that use radiopharmaceuticals.
Action Required
By April 1, 2025: Billing team must review and implement updated Medicare Advantage reimbursement guidelines for radiopharmaceutical agents. Access the full policy at the source URL to understand specific coding and billing requirements. Update billing procedures for nuclear medicine services to ensure compliance with new reimbursement rules.